FMD vaccines: Reflections on quality aspects for applicability in European disease control policy

Transboundary and Emerging Diseases

Volumn 55, Issue 1, 2008, Pages 46-56

  De Clercq, K ^a   Goris, N ^a   Barnett, P V ^b   MacKay, D K ^c  

^a VETERINARY AND AGROCHEMICAL RESEARCH CENTRE   (Belgium)

^b INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

^c EUROPEAN MEDICINES AGENCY   (United Kingdom)

Author keywords

Disease control policy; FMD vaccines; Quality aspects

Indexed keywords

VIRUS VACCINE;

ANIMAL; ARTICLE; EUROPE; FOOT AND MOUTH DISEASE; FOOT AND MOUTH DISEASE VIRUS; HEALTH CARE POLICY; IMMUNOLOGY; QUALITY CONTROL;

ANIMALS; EUROPE; FOOT-AND-MOUTH DISEASE; FOOT-AND-MOUTH DISEASE VIRUS; HEALTH POLICY; QUALITY CONTROL; VIRAL VACCINES;

FOOT-AND-MOUTH DISEASE VIRUS;

EID: 38649131977     PISSN: 18651674     EISSN: 18651682     Source Type: Journal    
DOI: 10.1111/j.1865-1682.2007.01012.x     Document Type: Article

References (95)

1. Ahl, R. B. Keller, 1987 : Diagnosis of foot-and-mouth disease and strain identification of the foot-and-mouth disease virus. Arch. Exp. Veterinarmed. 41, 784 790.
2. Ahl, R., B. Haas, R. J. Lorenz G. Wittman, 1990 : Alternative potency test of FMD vaccines and results of comparative antibody assays in different cell systems and ELISA. Report of the Session of the Research Group of the European Commission for the Control of Foot-and-mouth Disease, Lindholm, Denmark, 25-29 June, pp. 51 60.
3. de Avila Botton, S., M. C. Brum, E. Bautista, M. Koster, R. Weiblen, W. T. Golde M. J. Grubman, 2006 : Immunopotentiation of a foot-and-mouth disease virus subunit vaccine by interferon alpha. Vaccine 24, 3446 3456.
4. Bahnemann, H. G., 1990 : Inactivation of viral antigens for vaccine preparation with particular reference to the application of binary ethylenimine. Vaccine 8, 299 303.
5. Baranowski, E., C. M. Ruiz-Jarabo, F. Lim E. Domingo, 2001 : Foot-and-mouth disease virus lacking the VP1 G-H loop: the mutant spectrum uncovers interactions among antigenic sites for fitness gain. Virology 288, 192 202.
6. Barnard, A. L., A. Arriens, S. Cox, P. Barnett, B. Kristensen, A. Summerfield K. C. McCullough, 2005 : Immune response characteristics following emergency vaccination of pigs against foot-and-mouth disease. Vaccine 23, 1037 1047.
7. Barnett, P. V. H. Carabin, 2002 : A review of emergency foot-and-mouth disease (FMD) vaccines. Vaccine 20, 1505 1514.
8. Barnett, P. V. R. J. Statham, 1995 : Long term stability and potency of antigen concentrates held by the international vaccine bank (IVB). Report of the Session of the FAO European Commission for the Control of Foot-and-Mouth Disease, Rome, Italy, 5-7 April, pp. 60-65.
9. Barnett, P. V., L. Pullen, L. Williams T. R. Doel, 1996 : International bank for foot-and-mouth disease vaccine: assessment of Montanide ISA 25 and ISA 206, two commercially available oil adjuvants. Vaccine 14, 1187 1198.
10. Barnett, P. V., A. R. Samuel R. J. Statham, 2001 : The suitability of the 'emergency' foot-and-mouth disease antigens held by the International Vaccine Bank within a global context. Vaccine 19, 2107 2117.
11. Barnett, P. V., R. J. Statham, W. Vosloo D. T. Haydon, 2003 : Foot-and-mouth disease vaccine potency testing: determination and statistical validation of a model using a serological approach. Vaccine 21, 3240 3248.
12. Barnett, P. V., P. Keel, S. Reid, R. M. Armstrong, R. J. Statham, C. Voyce, N. Aggarwal S. J. Cox, 2004 : Evidence that high potency foot-and-mouth disease vaccine inhibits local virus replication and prevents the "carrier" state in sheep. Vaccine 22, 1221 1232.
13. Barteling, S. J. J. Vreeswijk, 1991 : Developments in foot-and-mouth disease vaccines. Vaccine 9, 75 88.
14. Barteling, S. J., H. Swam, D. A. Anemaet, C. Tuyn J. Vreeswijk, 1997 : Foot and-mouth disease vaccines from the European bank seem to be sufficiently stable for emergency vaccination. Report of the Session of the FAO Research Group of the Standing Technical Committee of the European Commission for the Control of Foot-and-Mouth Disease, Poiana Brasov, Romania, September, pp. 68-70.
15. Bartley, L. M., C. A. Donnelly R. M. Anderson, 2002 : Review of foot-and-mouth disease virus survival in animal excretions and on fomites. Vet. Rec. 151, 667 669.
16. Beignon, A. S., F. Brown, P. Eftekhari, E. Kramer, J. P. Briand, S. Muller C. D. Partidos, 2005 : A peptide vaccine administered transcutaneously together with cholera toxin elicits potent neutralising anti-FMDV antibody responses. Vet. Immunol. Immunopathol. 104, 273 280.
17. Berinstein, A., C. Tami, O. Taboga, E. Smitsaart E. Carrillo, 2000 : Protective immunity against foot-and-mouth disease virus induced by a recombinant vaccinia virus. Vaccine 18, 2231 2238.
18. Bolwell, C., N. R. Parry D. J. Rowlands, 1992 : Comparison between in vitro neutralization titres and in vivo protection against homologous and heterologous challenge induced by vaccines prepared from two serologically distinct variants of foot-and-mouth disease virus, serotype A22. J. Gen. Virol. 73, 727 731.
19. Borrego, B., P. Fernandez-Pacheco, L. Ganges, N. Domenech, N. Fernandez-Borges, F. Sobrino F. Rodriguez, 2006 : DNA vaccines expressing B and T cell epitopes can protect mice from FMDV infection in the absence of specific humoral responses. Vaccine 24, 3889 3899.
20. Brocchi, E., I. E. Bergmann, A. Dekker, D. J. Paton, D. J. Sammin, M. Greiner, S. Grazioli, F. De Simone, H. Yadin, B. Haas, N. Bulut, V. Malirat, E. Neitzert, N. Goris, S. Parida, K. Sorensen K. De Clercq, 2006 : Comparative evaluation of six ELISAs for the detection of antibodies to the non-structural proteins of foot-and-mouth disease virus. Vaccine 24, 6966 6979.
21. Commission of the European Communities, 1989 : Report from the Commission to the Council on a study carried out by the Commission on policies currently applied by Member States in the control of foot and mouth disease, Brussel, 18 October, Ref.: SEC (89) 1731 final.
22. Cox, S. P. Barnett, 2000 : Longevity of the antibody response in pigs and sheep following a single administration of high potency emergency FMD vaccine. Report of the Session of the FAO Research Group of the Standing Technical Committee of the European Commission for the Control of Foot-and-Mouth Disease, Borovets, Bulgaria, 5-8 September, pp. 247-254.
23. Cox, S. J., P. V. Barnett, P. Dani J. S. Salt, 1999 : Emergency vaccination of sheep against foot-and-mouth disease: protection against disease and reduction in contact transmission. Vaccine 17, 1858 1868.
24. Cox, S. J., N. Aggarwal, R. J. Statham P. V. Barnett, 2003 : Longevity of antibody and cytokine responses following vaccination with high potency emergency FMD vaccines. Vaccine 21, 1336 1347.
25. Cox, S. J., C. Voyce, S. Parida, S. M. Reid, P. A. Hamblin, D. J. Paton P. V. Barnett, 2005 : Protection against direct-contact challenge following emergency FMD vaccination of cattle and the effect on virus excretion from the oropharynx. Vaccine 23, 1106 1113.
26. Cox, S. J., C. Voyce, S. Parida, S. M. Reid, P. A. Hamblin, G. Hutchings, D. J. Paton P. V. Barnett, 2006 : Effect of emergency FMD vaccine antigen payload on protection, sub-clinical infection and persistence following direct contact challenge of cattle. Vaccine 24, 3184 3190.
27. De Clercq, K., 2000 : Proposal for revision of the FMD Monograph in the European Pharmacopoeia. Report of the Session of the FAO Research Group of the Standing Technical Committee of the European Commission for the Control of Foot-and-Mouth Disease, Borovets, Bulgaria, 5-8 September, pp. 198-205.
28. Defra, 2007 : FMD 2007. Summary Epidemiology Report. In : FMD Epidemiology Report 10.00, 09 August 2007. Available at: http://www.defra.gov. uk/footandmouth/pdf/fmd-epireport090807.pdf (consulted 9 September 2007).
29. Dekker, A., 2007 : Minimum size of holdings in antigen and vaccine banks. Report of the 37th General Session of the FAO European Commission for the Control of Foot-and-Mouth Disease, Rome, Italy.
30. Doel, T. R., 1985 : Prospects for improved foot and mouth disease vaccines. Vaccine 3, 35 36.
31. Doel, T. R., 1999 : Optimisation of the immune response to foot-and-mouth disease vaccines. Vaccine 17, 1767 1771.
32. Doel, T., 2001 : Repeated administration of maximum payload emergency vaccines made from inactivated purified antigen concentrates do not induce significant titres of antibodies against non-structural proteins of foot-and-mouth disease virus. Report of the Session of the FAO Research Group of the Standing Technical Committee of the European Commission for the Control of Foot-and-Mouth Disease, Island of Moen, Denmark, 12-15 September, pp. 88 92.
33. Doel, T. R., 2003a : Potency testing of foot-and-mouth disease vaccines: an industrial perspective. Proceedings of the International Symposium on foot and mouth disease organised by the European Directorate for the Quality of Medicines (EDQM), Council of Europe, Strasbourg, 17-18 March, pp. 41 47.
34. Doel, T. R., 2003b : FMD vaccines. Virus Res. 91, 81 99.
35. Doel, T. R., 2005 : Natural and vaccine induced immunity to FMD. Curr. Top. Microbiol. Immunol. 288, 103 131.
36. Doel, T. R. T. Collen, 1982 : Qualitative assessment of 146 S particles of foot-and-mouth disease virus in preparations destined for vaccines. J. Biol. Stand. 10, 69 81.
37. Doel, T. R., L. Williams P. V. Barnett, 1994 : Emergency vaccination against foot-and-mouth disease: rate of development of immunity and its implications for the carrier state. Vaccine 12, 592 600.
38. Donaldson, A. I. R. P. Kitching, 1989 : Transmission of foot-and-mouth disease by vaccinated cattle following natural challenge. Res. Vet. Sci. 46, 9 14.
39. Dus Santos, M. J., A. Wigdorovitz, E. Maradei, O. Periolo, E. Smitsaart, M. V. Borca A. M. Sadir, 2000 : A comparison of methods for measuring the antibody response in mice and cattle following vaccination against foot and mouth disease. Vet. Res. Commun. 24, 261 273.
40. Dus Santos, M. J., C. Carrillo, F. Ardila, R. D. Rios, P. Franzone, M. E. Piccone, A. Wigdorovitz M. V. Borca, 2005 : Development of transgenic alfalfa plants containing the foot and mouth disease virus structural polyprotein gene P1 and its utilization as an experimental immunogen. Vaccine 23, 1838 1843.
41. Eblé, P. L., A. Bouma, M. G. de Bruin, F. van Hemert-Kluitenberg, J. T. van Oirschot A. Dekker, 2004 : Vaccination of pigs two weeks before infection significantly reduces transmission of foot-and-mouth disease virus. Vaccine 22, 1372 1378.
42. Eblé, P. L., M. G. de Bruin, A. Bouma, F. van Hemert-Kluitenberg A. Dekker, 2006 : Comparison of immune responses after intra-typic heterologous and homologous vaccination against foot-and-mouth disease virus infection in pigs. Vaccine 24, 1274 1281.
43. Eblé, P. L., A. Bouma, K. Weerdmeester, J. A. Stegeman A. Dekker, 2007 : Serological and mucosal immune responses after vaccination and infection with FMDV in pigs. Vaccine 25, 1043 1054.
44. EMEA, 2004. Position Paper on Requirements for Vaccines against Foot-and-Mouth Disease. (EMEA/CVMP/775/ 02-FINAL) - http://www.emea.eu.int/pdfs/ vet/press/pp/077502en.pdf (consulted 07/10/2007).
45. Espinoza, A. M., E. Maradei, N. Mattion, G. Cadenazzi, G. Maddonni, B. Robiolo, J. La Torre, R. Bellinzoni E. Smitsaart, 2004 : Foot-and-mouth disease polyvalent oil vaccines inoculated repeatedly in cattle do not induce detectable antibodies to non-structural proteins when evaluated by various assays. Vaccine 23, 69 77.
46. EUFMD, F., 1993 : Minimum standards for Laboratories working with foot-and-mouth virus in vitro and in vivo (1985), as modified in 1993. Report of the Session of the FAO European Commission for the Control of Foot-and-Mouth Disease, Rome, Italy, April.
47. European Pharmacopoeia, 2006 : Foot-and-Mouth Disease (ruminants) Vaccine (inactivated), 5th edn, 04/2005:0063, version 5.5. European Directorate for the Quality of Medicines (EDQM), Council of Europe, Strasbourg, France.
48. Forman, A. J. A. J. Garland, 2002 : Foot and mouth disease: the future of vaccine banks. Rev. Sci. Tech. 21, 601 612.
49. Goris, N., P. Merkelbach-Peters, V. I. Diev, D. Verloo, V. M. Zakharov, H. -P. Kraft K. De Clercq, 2007a : European Pharmacopoeia foot-and-mouth disease vaccine potency testing in cattle: between test variability and its consequences. Vaccine 25, 3373 3379.
50. Goris, N., N. Praet, D. Sammin, H. Yadin, D. Paton, E. Brocchi, D. Berkvens K. De Clercq, 2007b : Foot-and-mouth disease non-structural protein serology in cattle: use of a Bayesian framework to estimate diagnostic sensitivity and specificity of six ELISA tests and true prevalence in the field. Vaccine 25, 7177 7196.
51. Hohlich, B. J., K. H. Wiesmuller, B. Haas, W. Gerner, R. Correa, H. R. Hehnen, T. Schlapp, E. Pfaff A. Saalmuller, 2003 : Induction of an antigen-specific immune response and partial protection of cattle against challenge infection with foot-and-mouth disease virus (FMDV) after lipopeptide vaccination with FMDV-specific B-cell epitopes. J. Gen. Virol. 84, 3315 3324.
52. Kitching, R. P., 1998 : A recent history of foot-and-mouth disease. J. Comp. Pathol. 118, 89 108.
53. Li, G., W. Chen, W. Yan, K. Zhao, M. Liu, J. Zhang, L. Fei, Q. Xu, Z. Sheng, Y. Lu Z. Zheng, 2004 : Comparison of immune responses against foot-and-mouth disease virus induced by fusion proteins using the swine IgG heavy chain constant region or beta-galactosidase as a carrier of immunogenic epitopes. Virology 328, 274 281.
54. Li, Y., N. Aggarwal, H. H. Takamatsu, C. M. Sterling, C. Voyce P. V. Barnett, 2006 : Enhancing immune responses against a plasmid DNA vaccine encoding a FMDV empty capsid from serotype O. Vaccine 24, 4602 4606.
55. Mackay, D., 2004 : Harmonising testing requirements for FMD vaccines. Dev. Biol. (Basel) 119, 383 386.
56. McCullough, K. C., L. Bruckner, R. Schaffner, W. Fraefel, H. K. Müller U. Kihm, 1992 : Relationship between the anti-FMD virus antibody response reaction as measured by different assays, and protection in vivo against challenge infection. Vet. Microbiol. 30, 99 112.
57. McVicar, J. W. P. Sutmoller, 1976 : Growth of foot-and-mouth disease virus in the upper respiratory tract of non-immunized, vaccinated, and recovered cattle after intranasal inoculation. J. Hyg. (Lond) 76, 467 481.
58. Moraes, M. P., J. Chinsangaram, M. C. Brum M. J. Grubman, 2003 : Immediate protection of swine from foot-and-mouth disease: a combination of adenoviruses expressing interferon alpha and a foot-and-mouth disease virus subunit vaccine. Vaccine 22, 268 279.
59. Moraes, M. P., T. de Los Santos, M. Koster, T. Turecek, H. Wang, V. G. Andreyev M. J. Grubman, 2007 : Enhanced antiviral activity against foot-and-mouth disease virus by a combination of type I and II porcine interferons. J. Virol. 81, 7124 7135.
60. OIE, 1975. Reports of the XIVth Conference of the OIE Permanent Commission on Foot and Mouth Disease, Paris, March 11-14, 1975. Bull. Off. Int. Epizoot. 83, 1 141.
61. OIE, 2004a : Manual for Diagnostic Tests and Vaccines for Terrestrial Animals, 5th edition. OIE, Paris, France.
62. OIE, 2004b : Terrestrial Animal Health Code, 13th edition. OIE, Paris, France.
63. Orsel, K., A. Dekker, A. Bouma, J. A. Stegeman M. C. de Jong, 2005 : Vaccination against foot and mouth disease reduces virus transmission in groups of calves. Vaccine 23, 4887 4894.
64. Orsel, K., M. C. de Jong, A. Bouma, J. A. Stegeman A. Dekker, 2007a : The effect of vaccination on foot and mouth disease virus transmission among dairy cows. Vaccine 25, 327 335.
65. Orsel, K., M. C. de Jong, A. Bouma, J. A. Stegeman A. Dekker, 2007b : Foot and mouth disease virus transmission among vaccinated pigs after exposure to virus shedding pigs. Vaccine 25, 6381 6391.
66. Orsel, K., A. Dekker, A. Bouma, J. A. Stegeman M. C. de Jong, 2007c : Quantification of foot and mouth disease virus excretion and transmission within groups of lambs with and without vaccination. Vaccine 25, 2673 2679.
67. Pacheco, J. M., M. C. Brum, M. P. Moraes, W. T. Golde M. J. Grubman, 2005 : Rapid protection of cattle from direct challenge with foot-and-mouth disease virus (FMDV) by a single inoculation with an adenovirus-vectored FMDV subunit vaccine. Virology 337, 205 209.
68. Palma, E. L., 2004 : A global virtual network for foot-and-mouth disease in case of emergency. Dev. Biol. (Basel) 119, 317 331.
69. Paton, D., N. Ferris, J. Valarcher, N. Knowles B. Statham, 2005 : FMD FAO WRL report 2005. Report of the FAO Executive Committee of the Standing Technical Committee of the European Commission for the Control of Foot-and-Mouth Disease, Den Haag, the Netherlands, 29-30 November, pp. 60 65.
70. Paton, D., K. De Clercq, M. Greiner, A. Dekker, E. Brocchi, I. Bergmann, D. Sammin, S. Gubbin S. Parida, 2006 : Application of non-structural protein antibody tests in substantiating freedom from foot-and-mouth disease virus infection after emergency vaccination of cattle. Vaccine 24, 6503 6512.
71. Pay, T. W. F. P. J. Hingley, 1987 : Correlation of 140S antigen dose with the serum neutralizing antibody response and the level of protection induced in cattle by foot and mouth disease vaccines. Vaccine 5, 60 64.
72. Pay, T. W. F. P. J. Hingley, 1992a : Foot and mouth disease vaccine potency tests in cattle: the interrelationship of antigen dose, serum neutralizing antibody response and protection from challenge. Vaccine 10, 669 706.
73. Pay, T. W. F. P. J. Hingley, 1992b : A potency test method for foot and mouth disease vaccine based on the serum neutralizing antibody response produced in cattle. Vaccine 10, 707 713.
74. Robiolo, B., P. R. Grigera, O. H. Periolo, C. Seki, T. Bianchi, E. Maradei J. L. La torre, 1995 : Assessment of foot and mouth disease vaccine potency by liquid-phase blocking ELISA: a proposal for an alternative to the challenge procedure in Argentina. Vaccine 13, 1346 1352.
75. Rodriguez, L. L., J. Barrera, E. Kramer, J. Lubroth, F. Brown W. T. Golde, 2003 : A synthetic peptide containing the consensus sequence of the G-H loop region of foot-and-mouth disease virus type-O VP1 and a promiscuous T-helper epitope induces peptide-specific antibodies but fails to protect cattle against viral challenge. Vaccine 21, 3751 3756.
76. Rweyemamu, M. M., L. Black, A. Boge, A. C. Thorne G. M. Terry, 1984 : The relationship between 140S antigen dose in aqueous foot-and-mouth disease vaccines and the serum antibody response of cattle. J. Biol. Stand. 12, 111 120.
77. Ryan, J., 2001 : The availability of foot and mouth disease vaccine for emergency vaccination in Europe. Report of the Session of the FAO European Commission for the Control of Foot-and-Mouth Disease, Rome, Italy, 21-23 March, pp. 117 127.
78. Salt, J. S., P. V. Barnett, P. Dani L. Williams, 1998 : Emergency vaccination of pigs against foot-and-mouth disease: protection against disease and reduction in contact transmission. Vaccine, 16, 746 754.
79. SCAHAW, 2003 : Diagnostic techniques and vaccines for foot-and-mouth disease, classical swine fever, avian influenza and some other important OIE list A diseases. Report of the Scientific Committee on Animal Health and Animal Welfare, Brussels, Belgium, 24-25 April, pp. 17 18.
80. Sellers, R. F., K. A. Herniman I. D. Gumm, 1977 : The airborne dispersal of foot-and-mouth disease virus from vaccinated and recovered pigs, cattle and sheep after exposure to infection. Res. Vet. Sci. 23, 70 75.
81. Shao, H. J., L. Chen Y. B. Su, 2005 : DNA fragment encoding human IL-1beta 163-171 peptide enhances the immune responses elicited in mice by DNA vaccine against foot-and-mouth disease. Vet. Res. Commun. 29, 35 46.
82. Smitsaart, E., N. Mattion, G. Mazzuca, B. Robiolo, E. Maradei, J. Filippi, A. Sadir, A. Falczuk, J. La Torre, A. Pedemonte, R. Dáloia, O. Periolo, G. Cadenazzi, E. Palma R. Bellinzoni, 2002 : Foot-and-Mouth disease in Argentina: development of vaccines for emergency, control and eradication of the disease. Report of the Session of the FAO Research Group of the Standing Technical Committee of the European Commission for the Control of Foot-and-Mouth Disease, Izmir, Turkey, 17-20 September, pp. 336 349.
83. Smitsaart, E., A. M. Espinoza, R. Sanguinetti, J. Filippi, A. Ham R. Bellinzoni, 2004 : Addition of saponin to double oil emulsion FMD vaccines enhances specific antibody responses in cattle and pigs. Report of the Session of the FAO Research Group of the Standing Technical Committee of the European Commission for the Control of Foot-and-Mouth Disease, Crete, Greece, 12-15 October, pp. 344 351.
84. Srinivasan, V. A., S. B. Nagendra Kumar, M. Madhan Mohan, V. Maroudam, P. Santha Kumar, S. Parida, J. Horsington D. J. Paton, 2006 : Preliminary results to evaluate cross-protection between O1 Manisa and O1 Campos in cattle. Report of the Session of the FAO Research Group of the Standing Technical Committee of the European Commission for the Control of Foot-and-Mouth Disease, Paphos, Cyprus, 15-21 October, Appendix 33.
85. Summerfield, A., L. Guzylack-Piriou, L. Saurer K. C. McCullough, 2004 : Novel immunological approaches for emergency FMD vaccines inducing mucosal immunity. Report of the Session of the FAO Research Group of the Standing Technical Committee of the European Commission for the Control of Foot-and-Mouth Disease, Crete, Greece, 12-15 October, 358.
86. Sun, M., K. Qian, N. Su, H. Chang, J. Liu G. Shen, 2003 : Foot-and-mouth disease virus VP1 protein fused with cholera toxin B subunit expressed in Chlamydomonas reinhardtii chloroplast. Biotechnol. Lett. 25, 1087 1092.
87. Sutmöller, P. A. Vieira, 1980 : The relationship of neutralizing antibody titers for foot-and-mouth disease virus and the protection of cattle. Bltn. Centro Panamericano Fiebre Aftosa 39-40, 57 62.
88. Van Maanen, C. C. Terpstra, 1989 : Comparison of a liquid-phase blocking sandwich ELISA and a serum neutralisation test to evaluate immunity in potency tests of foot-and-mouth disease vaccines. J. Immunol. Methods 124, 111 119.
89. Van Rensburg, H. G. P. W. Mason, 2002 : Construction and evaluation of a recombinant foot-and-mouth disease virus: implications for inactivated vaccine production. Ann. N. Y. Acad. Sci. 969, 83 87.
90. Vianna Filho, Y. L., V. Astudillo, I. Gomes, G. Fernández, C. E. Rozas, J. A. Ravison A. Alonso, 1993 : Potency control of foot-and-mouth disease vaccine in cattle. Comparison of the 50% protective dose and the protection against generalization. Vaccine 11, 1424 1428.
91. Wang, C. Y., T. Y. Chang, A. M. Walfield, J. Ye, M. Shen, S. P. Chen, M. C. Li, Y. L. Lin, M. H. Jong, P. C. Yang, N. Chyr, E. Kramer F. Brown, 2002 : Effective synthetic peptide vaccine for foot-and-mouth disease in swine. Vaccine 20, 2603 2610.
92. Wang, J. H., C. M. Liang, J. M. Peng, J. J. Shieh, M. H. Jong, Y. L. Lin, M. Sieber S. M. Liang, 2003 : Induction of immunity in swine by purified recombinant VP1 of foot-and-mouth disease virus. Vaccine 21, 3721 3729.
93. Wang, C. Y., S. Lynn, M. H. Jong, Y. L. Lin, T. Y. Chang, A. M. Walfield, A. Wang, J. Wang C. Sia, 2004 : Full Protection in Pigs against FMDV Challenge following Single Dose of Synthetic Emergency FMD Vaccine. Report of the Session of the FAO Research Group of the Standing Technical Committee of the European Commission for the Control of Foot-and-Mouth Disease, Crete, Greece, 12-15 October, pp. 365 375.
94. Wright, P., S. Edwards, A. Diallo R. Jacobson, 2006 : Development of a framework for international certification by OIE of diagnostic tests validated as fit for purpose. Dev. Biol. (Basel) 126, 43 51 Discussion 324-325.
95. Zhang, Z., J. B. Bashiruddin, C. Doel, J. Horsington, S. Durand S. Alexandersen, 2006 : Cytokine and Toll-like receptor mRNAs in the nasal-associated lymphoid tissues of cattle during foot-and-mouth disease virus infection. J. Comp. Pathol. 134, 56 62.